FDA NDC Directory · JSON-LD · Markdown

LENALIDOMIDE

NDC 0574-1415 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namelenalidomide
Labeler / ManufacturerPadagis US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA217265
Dosage form / routeCAPSULE · ORAL
Active ingredientsLENALIDOMIDE (15 mg/1)
Marketing started20260131
Package count1

External sources

Source: openFDA. Public-domain (CC0).